scholarly journals The retrospective research of enteral nutrition with medium-chain triglyceride and total parenteral nutrition support of postoperative chylothorax in adults

2020 ◽  
Vol 8 ◽  
pp. 205031212093822
Author(s):  
Jie Zheng ◽  
Ying-Yi Chen ◽  
Chun-Ying Zhang ◽  
Wen-Qian Zhang ◽  
Zhi-Yong Rao

Background: Chylothorax is caused by thoracic lymphatic system injuries that leads to the lymph extravasating into the thoracic cavity. There are few reports comparing the therapeutic effects of enteral nutrition with medium-chain triglyceride and total parenteral nutrition, and the results are inconsistent. Our study aimed to research the optimum nutrition support method for chylothorax. Study design: We retrospectively reviewed 35 chylothorax patients after heart and chest surgery from 2014 to 2018, at West China Hospital of Sichuan University, among them there were 27 post-heart surgery patients. We analyzed the therapeutic effects and costs of enteral nutrition with medium-chain triglyceride (E group) and total parenteral nutrition (T group) for chylothorax. Results: The results were similar in patients with all surgeries and patients with only post heart surgery. The total cost during hospitalization in E group was higher than T group ( P < 0.01), whereas the nutrition support cost was lower ( P < 0.001). The length of hospital stay was longer in E group than T group ( P > 0.05). Time from admission to surgery was shorter and from surgery to chylothorax diagnosis was longer in E group compared with T group. Time to resolution and removal of drainage was shorter in E group than T group but the differences were not significant. Conclusion: The therapeutic effects in enteral nutrition with medium-chain triglyceride and total parenteral nutrition had no obvious differences. Moreover, enteral nutrition with medium-chain triglyceride is safer and more economical. Therefore, we suggest that enteral nutrition with medium-chain triglyceride could be the first choice to treat postoperative chylothorax when the gastrointestinal tract function is allowed, and this result could be considered for postoperative chylous ascites.

2015 ◽  
Vol 108 (12) ◽  
pp. 748-753 ◽  
Author(s):  
Mario H. Mueller ◽  
Katherine Vandenbussche ◽  
Maria Pelliccia ◽  
Myles Smith ◽  
Paul Karanicolas ◽  
...  

1990 ◽  
Vol 1 (9) ◽  
pp. 462-470 ◽  
Author(s):  
E.Scott Swenson ◽  
Lisa E. Crosby ◽  
Vigen K. Babayan ◽  
George L. Blackburn ◽  
Bruce R. Bistrian

1986 ◽  
Vol 10 (1) ◽  
pp. 38-46 ◽  
Author(s):  
Raymond F. H. Dawes ◽  
Gavin T. Royle ◽  
Ashley R. Dennison ◽  
Phillip J. Crowe ◽  
Madeline Ball

1997 ◽  
Vol 8 (7) ◽  
pp. 288-296
Author(s):  
Toshiaki Iba ◽  
Yoshihiro Yagi ◽  
Akio Kidokoro ◽  
Syoichi Fuse ◽  
Yoichi Ohno ◽  
...  

Pharmacy ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 121
Author(s):  
Roland N. Dickerson ◽  
Christopher T. Buckley

Propofol, a commonly used sedative in the intensive care unit, is formulated in a 10% lipid emulsion that contributes 1.1 kcals per mL. As a result, propofol can significantly contribute to caloric intake and can potentially result in complications of overfeeding for patients who receive concurrent enteral or parenteral nutrition therapy. In order to avoid potential overfeeding, some clinicians have empirically decreased the infusion rate of the nutrition therapy, which also may have detrimental effects since protein intake may be inadequate. The purpose of this review is to examine the current literature regarding these issues and provide some practical suggestions on how to restrict caloric intake to avoid overfeeding and simultaneously enhance protein intake for patients who receive either parenteral or enteral nutrition for those patients receiving concurrent propofol therapy.


1996 ◽  
Vol 20 (3) ◽  
pp. 206-210 ◽  
Author(s):  
Donna Chrisanderson ◽  
Douglas C. Heimburger ◽  
Sarah L. Morgan ◽  
Wilma J. Geels ◽  
Kathy L. Henry ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document